Filing Details

Accession Number:
0001209191-23-054425
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-03 19:38:21
Reporting Period:
2023-11-01
Accepted Time:
2023-11-03 19:38:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1658247 Crinetics Pharmaceuticals Inc. CRNX Pharmaceutical Preparations (2834) 263744114
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1702265 Marc Wilson C/O Crinetics Pharmaceuticals, Inc.
10222 Barnes Canyon Road, Bldg 2
San Diego CA 92121
Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-11-01 10,000 $9.28 105,601 No 4 M Direct
Common Stock Disposition 2023-11-01 10,000 $28.75 95,601 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified stock option (Right to Buy) Disposition 2023-11-01 10,000 $0.00 10,000 $9.28
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
61,185 2028-05-24 No 4 M Direct
Footnotes
  1. Includes 443 shares acquired under the Issuer's Employee Stock Purchase Plan.
  2. The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sales price of $28.75 per share. The range of sales prices on the transaction date was $28.14 to $29.07 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
  3. 1/48th of the shares subject to the option vested on June 25, 2018, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.